INCOME TAXES (Tables)

12 Months Ended

Mar. 31, 2025

Income Tax Disclosure [Abstract]

Schedule of deferred tax assets

	YEAR ENDED MARCH 31,
	2025			2024
Deferred tax assets:
Research and development credit carryforwards	$	3,442,000		$	3,442,000
Capitalized research and development costs		519,000			646,000
Net operating loss carryforwards(1)		30,022,000			26,927,000
Stock compensation		415,000			2,244,000
Total deferred tax assets		34,398,000			33,259,000
Total deferred tax liabilities		–			–
Net deferred tax assets		34,398,000			33,259,000
Valuation allowance for deferred tax assets		(34,398,000	)		(33,259,000	)
Net deferred tax assets	$	–		$	–

 ______________

(1) Pursuant to Internal Revenue Code Section 382, use of our tax net operating loss carryforwards may be limited. The amount of the annual limitation, if any, will be determined based on the value of the Company immediately prior to an ownership change. Subsequent ownership changes may further affect the limitation in future years. If and when the Company utilizes the NOL carryforwards in a future period, it will perform an analysis to determine the effect, if any, of these loss limitation rules on the NOL carryforward balances.

Schedule of provision for income taxes

	2025			2024
Income taxes (benefit) at federal statutory rate of 21.00%	$	(2,811,000	)	$	(2,564,000	)
Tax effect on non-deductible expenses and credits		1,000			2,000
True up items		132,000			(29,000	)
Expiration of net operating loss carryforwards (1)		204,000			204,000
Change in valuation allowance		2,474,000			2,387,000
Income Tax Expense (Benefit)	$	–		$	–

 ______________

(1) Pursuant to Internal Revenue Code Section 382, use of our tax net operating loss carryforwards may be limited.